Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 366 articles:
HTML format



Single Articles


    May 2024
  1. MOTWANI KK, Alizadeh M, Abutaleb A, Grossman J, et al
    Correction to: Correlation Between Plasma and Fecal Biomarkers and Patient?Reported Outcomes in Patients with Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2024 May 16. doi: 10.1007/s10620-024-08469.
    PubMed    


  2. EMERSON C, Skvarc D, Mikocka-Walus A, Olive L, et al
    People with Inflammatory Bowel Disease Prefer Cognitive Behavioral Therapy for Fatigue Management: A Conjoint Analysis.
    Dig Dis Sci. 2024 May 11. doi: 10.1007/s10620-024-08468.
    PubMed     Abstract available


  3. MEDAWAR E, Djinbachian R, Crainic IP, Safih W, et al
    Serrated Polyps in Inflammatory Bowel Disease Indicate a Similar Risk of Metachronous Colorectal Neoplasia as in the General Population.
    Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08456.
    PubMed     Abstract available


  4. SCHREIBER S, Hunter Gibble T, Panaccione R, Rubin DT, et al
    Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study.
    Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08434.
    PubMed     Abstract available


  5. SIFFLEDEEN J, Singh S, Shulman SM, Igoe J, et al
    Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada Trial.
    Dig Dis Sci. 2024;69:1636-1648.
    PubMed     Abstract available


    April 2024
  6. GREYWOODE R, Larson J, Peraza J, Clark R, et al
    Risk of Adverse Cardiovascular Outcomes in Postmenopausal Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Apr 29. doi: 10.1007/s10620-024-08348.
    PubMed     Abstract available


  7. LAMICHHANE N, Melas N, Bergqvist V, Ekholm NP, et al
    Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Apr 18. doi: 10.1007/s10620-024-08422.
    PubMed     Abstract available


  8. KANE K, Velayos FS, Lee JK, Cherny S, et al
    A Response-able Diagnosis: Type 2 Autoimmune Pancreatitis in the Setting of Ulcerative Colitis.
    Dig Dis Sci. 2024 Apr 18. doi: 10.1007/s10620-024-08408.
    PubMed    


  9. VAN LINSCHOTEN RCA, Jansen FM, Pauwels RWM, Smits LJT, et al
    A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
    Dig Dis Sci. 2024 Apr 9. doi: 10.1007/s10620-024-08410.
    PubMed     Abstract available


  10. MOTWANI KK, Alizadeh M, Abutaleb A, Grossman J, et al
    Correlation Between Serum and Fecal Biomarkers and Patient-Reported Outcomes in Patients with Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08421.
    PubMed     Abstract available


  11. HARRIS S, Feagan BG, Hanauer S, Vermeire S, et al
    Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease.
    Dig Dis Sci. 2024 Apr 3. doi: 10.1007/s10620-024-08391.
    PubMed     Abstract available


  12. DJALAL A, Wong SY, Colombel JF, Ungaro R, et al
    Problem with Hookups: Perianal Fistula After Ileal Pouch-Anal Anastomosis.
    Dig Dis Sci. 2024;69:1102-1104.
    PubMed    


  13. CLINTON J, Motwani KK, Schwartz S, McCarthy P, et al
    Upadacitinib as Rescue Therapy for the Treatment of Acute Severe Colitis in an Acute Care Setting.
    Dig Dis Sci. 2024;69:1105-1109.
    PubMed     Abstract available


  14. SINGH A, Mahajan R, Midha V, Kaur K, et al
    Effectiveness of Tofacitinib in Ulcerative Proctitis Compared to Left Sided Colitis and Pancolitis.
    Dig Dis Sci. 2024;69:1389-1402.
    PubMed     Abstract available


    March 2024
  15. FIELD J, Shah ND, Memel Z, Mahadevan U, et al
    Exclusive Yet Effective: The Crohn's Disease Exclusion Diet as Treatment for Medication-Refractory Disease.
    Dig Dis Sci. 2024 Mar 30. doi: 10.1007/s10620-024-08345.
    PubMed    


  16. CARVALHAS GABRIELLI AM, Ferretti F, Monico CM, Tombetti E, et al
    Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study.
    Dig Dis Sci. 2024 Mar 26. doi: 10.1007/s10620-024-08394.
    PubMed     Abstract available


  17. KELLAR A, Dolinger MT, Spencer EA, Dubinsky MC, et al
    Real-World Outcomes of Dual Advanced Therapy in Children and Young Adults with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Mar 23. doi: 10.1007/s10620-024-08379.
    PubMed     Abstract available


  18. PEYRIN-BIROULET L, Bossuyt P, Bettenworth D, Loftus EV Jr, et al
    Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.
    Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-023-08252.
    PubMed     Abstract available


  19. DEBOLT CA, Gottlieb ZS, Rao MG, Johnson S, et al
    Low-Dose Aspirin Use Does Not Increase Disease Activity in Pregnant Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Mar 16. doi: 10.1007/s10620-024-08364.
    PubMed     Abstract available


  20. SAHYOUN LC, Fetene J, McMillan C, Protiva P, et al
    Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Mar 11. doi: 10.1007/s10620-024-08355.
    PubMed     Abstract available


  21. OLIVEIRA R, Martins V, de Sousa HT, Roseira J, et al
    Food-Related Quality of Life and Its Predictors in Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Mar 8. doi: 10.1007/s10620-024-08333.
    PubMed     Abstract available


  22. KOCHAR B, Rusher A, Araka E, Glasser R, et al
    Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2024;69:766-774.
    PubMed     Abstract available


  23. STALLMACH A, Grunert PC
    Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies.
    Dig Dis Sci. 2024;69:657-659.
    PubMed    


  24. VEGA P, Huguet JM, Gomez E, Rubio S, et al
    IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management.
    Dig Dis Sci. 2024;69:749-765.
    PubMed     Abstract available


    February 2024
  25. KOLOSKI N, Shah A, Kaan I, Ben Jacob R, et al
    Healthcare Utilization Patterns: Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Gastroesophageal Reflux Disease.
    Dig Dis Sci. 2024 Feb 24. doi: 10.1007/s10620-024-08297.
    PubMed     Abstract available


  26. SU W, Liang X, Lu H, Zhang J, et al
    Concurrent Arterial and Venous Thromboses in Ulcerative Colitis: A Complex Case of Multiorgan Involvement.
    Dig Dis Sci. 2024 Feb 20. doi: 10.1007/s10620-024-08268.
    PubMed    


  27. HUSSAIN N, Trivedi PJ
    Risk Stratification in Primary Sclerosing Cholangitis: Does Size Matter?
    Dig Dis Sci. 2024 Feb 12. doi: 10.1007/s10620-023-08262.
    PubMed    


  28. WEIDNER J
    IBD: Who Knows Best?
    Dig Dis Sci. 2024;69:324-325.
    PubMed    


    January 2024
  29. SINGH A, Bhardwaj A, Tripathi A, Ranjan MK, et al
    Burden of Anxiety, Depression and Perceived Stress in Patients with Inflammatory Bowel Disease: A Cohort Study from North India.
    Dig Dis Sci. 2024 Jan 28. doi: 10.1007/s10620-023-08242.
    PubMed     Abstract available


  30. EIDELBERG A, Axelrad J, Chedid V, Ballou S, et al
    Sexual Health in Sexual and Gender Minority Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Jan 24. doi: 10.1007/s10620-023-08253.
    PubMed     Abstract available


  31. MALIK A, Liu BD, Zhu L, Kaelber D, et al
    A Comprehensive Global Population-Based Analysis on the Coexistence of Eosinophilic Esophagitis and Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-024-08283.
    PubMed     Abstract available


  32. PARK J, Chun J, Park SJ, Park JJ, et al
    Effectiveness and Tolerability of Methotrexate Combined with Biologics in Patients with Crohn's Disease: A Multicenter Observational Study.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08237.
    PubMed     Abstract available


  33. ZHANG Y, Wang C, Wu L, Bai C, et al
    Epithelial CRL4(DCAF2) Is Critical for Maintaining Intestinal Homeostasis Against DSS-Induced Colitis by Regulating the Proliferation and Repair of Intestinal Epithelial Cells.
    Dig Dis Sci. 2024;69:66-80.
    PubMed     Abstract available


  34. PALLA AH
    Regular or DCAF2: How CRL4(DCAF2) Affects IBD-Related Mucosal Injury.
    Dig Dis Sci. 2024;69:3-4.
    PubMed    


  35. LEVITTE S
    Point-of-Care Assays for Infliximab Therapeutic Drug Monitoring in Patients with IBD: Is Quicker Better?
    Dig Dis Sci. 2024;69:5-6.
    PubMed    


    December 2023
  36. MIYATANI Y, Choi D, Choi NK, Rubin DT, et al
    Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease.
    Dig Dis Sci. 2023 Dec 19. doi: 10.1007/s10620-023-08182.
    PubMed     Abstract available


  37. VERNON-ROBERTS A, Blay L, Day AS
    Knowledge Levels About Inflammatory Bowel Disease Vary Between Healthcare Professional Groups.
    Dig Dis Sci. 2023 Dec 12. doi: 10.1007/s10620-023-08191.
    PubMed     Abstract available


  38. COHEN NA, Choi D, Garcia N, Choi NK, et al
    Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center.
    Dig Dis Sci. 2023 Dec 12. doi: 10.1007/s10620-023-08178.
    PubMed     Abstract available


  39. MASSIRONI S, Laffusa A, Parigi TL, Danese S, et al
    Standardizing Endoscopic Reporting in Patients with IBD: JEDII to the Rescue?
    Dig Dis Sci. 2023;68:4287-4289.
    PubMed    


  40. CONSTANT BD, Scott FI
    The PA System: Is Prior Authorization for Dose Escalation of IBD Biologic Therapy a Tolerable Alternative or a Perpetual Annoyance?
    Dig Dis Sci. 2023;68:4279-4281.
    PubMed    


    November 2023
  41. GU P, Dube S, Lee Y, Yang S, et al
    Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD).
    Dig Dis Sci. 2023 Nov 28. doi: 10.1007/s10620-023-08192.
    PubMed     Abstract available


  42. VALDES-DELGADO T, Aguado-Paredes A, Merino-Bohorquez V, Martin-Manzanares J, et al
    Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA.
    Dig Dis Sci. 2023 Nov 9. doi: 10.1007/s10620-023-08139.
    PubMed     Abstract available


    October 2023
  43. PIPICELLA JL, Vernon-Roberts A, Dutt S, Giles E, et al
    Co-design and Consultation Ensure Consumer Needs Are Met: Building an eHealth Platform for Children with Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Oct 28. doi: 10.1007/s10620-023-08146.
    PubMed     Abstract available


  44. BERINSTEIN EM, Sheehan JL, Jacob J, Steiner CA, et al
    Correction to: Efficacy and Safety of Dual Targeted Therapy for Partially or Non?responsive Inflammatory Bowel Disease: A Systematic Review of the Literature.
    Dig Dis Sci. 2023 Oct 27. doi: 10.1007/s10620-023-08130.
    PubMed    


  45. LAW CCY, Peraza J, Viera Feliciano N, Ungaro RC, et al
    Do We Need AI to Diagnose AI? Diagnosis and Management of Adrenal Insufficiency Following Steroid Therapy in a Patient with Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Oct 13. doi: 10.1007/s10620-023-08123.
    PubMed    


  46. MCCURDY JD, Chen JH, Golden S, Kukaswadia A, et al
    Perianal Fistulas Are Associated with Persistently Higher Direct Health Care Costs in Crohn's Disease: A Population-Based Study.
    Dig Dis Sci. 2023 Oct 5. doi: 10.1007/s10620-023-08096.
    PubMed     Abstract available


  47. PEREYRA L, Gomez EE, Gonzalez RA, Smolarczuk A, et al
    Impact of an Educational Mobile App on Inflammatory Bowel Disease Colonoscopy Report Quality.
    Dig Dis Sci. 2023 Oct 5. doi: 10.1007/s10620-023-08120.
    PubMed     Abstract available


  48. MAAS L, Gao R, Cusumano V, Spartz E, et al
    Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn's Perianal Fistulae.
    Dig Dis Sci. 2023;68:3994-4000.
    PubMed     Abstract available


    September 2023
  49. DUNLEAVY KA, Raffals LE, Camilleri M
    Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics.
    Dig Dis Sci. 2023 Sep 29. doi: 10.1007/s10620-023-08122.
    PubMed     Abstract available


  50. DALAL RS, Baranov E, Li J, Hong X, et al
    Small Cells, Big Problems: Small Cell Carcinoma of the Rectal Cuff After Ileal-Pouch Anal Anastomosis in a Patient with Ulcerative Colitis.
    Dig Dis Sci. 2023 Sep 22. doi: 10.1007/s10620-023-08110.
    PubMed    


  51. SHAH NB, Zuckerman AD, Hosteng KR, Fann J, et al
    Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Sep 19. doi: 10.1007/s10620-023-08098.
    PubMed     Abstract available


  52. COATES MD, Dalessio S, Walter V, Stuart A, et al
    Lifestyle Factors Associated with Abdominal Pain in Quiescent Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Sep 15. doi: 10.1007/s10620-023-08075.
    PubMed     Abstract available


  53. PERRY CL, Rhudy CN
    Urban Legend: Addressing Knowledge Gaps in Inflammatory Bowel Disease Epidemiology.
    Dig Dis Sci. 2023 Sep 15. doi: 10.1007/s10620-023-08073.
    PubMed    


  54. LIM J, Rezaie A
    Irritable Bowel Syndrome-Like Symptoms in Quiescent Inflammatory Bowel Disease: A Practical Approach to Diagnosis and Treatment of Organic Causes.
    Dig Dis Sci. 2023 Sep 11. doi: 10.1007/s10620-023-08095.
    PubMed     Abstract available


  55. MORTON H, Coad J, Pedley KC, Irwin JR, et al
    Incidence of Inflammatory Bowel Disease in New Zealand Remains High, Findings in the Manawatu Region.
    Dig Dis Sci. 2023 Sep 2. doi: 10.1007/s10620-023-08070.
    PubMed     Abstract available


    August 2023
  56. CHIOREAN M, Ha C, Hur P, Sharma PP, et al
    Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database.
    Dig Dis Sci. 2023 Aug 28. doi: 10.1007/s10620-023-08063.
    PubMed     Abstract available


  57. CUSHING K, Gudjonsson JE, Speliotes E, Higgins PDR, et al
    An Assessment of Comparative Medication Durability in Inflammatory Bowel Disease Patients With and Without Co-morbid Psoriasis, Rheumatoid Arthritis, and/or Enteropathic Arthritis.
    Dig Dis Sci. 2023 Aug 9. doi: 10.1007/s10620-023-08062.
    PubMed     Abstract available


  58. LI T, Click B, Bachour S, Sachs M, et al
    Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn's Disease.
    Dig Dis Sci. 2023 Aug 7. doi: 10.1007/s10620-023-08044.
    PubMed     Abstract available


  59. FUDMAN DI
    Monitoring Postoperative Crohn's Disease-Closing the Gap.
    Dig Dis Sci. 2023 Aug 7. doi: 10.1007/s10620-023-08051.
    PubMed    


    July 2023
  60. LEE DU, Menegas S, Lee KJ, Pu A, et al
    Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis.
    Dig Dis Sci. 2023 Jul 14. doi: 10.1007/s10620-023-08023.
    PubMed     Abstract available


  61. SLEIMAN J, Patel M, Khan MZ, Falloon K, et al
    Sweet Syndrome Associated with Active Inflammatory Bowel Disease: A Case Series of a Rare Extra-intestinal Manifestation.
    Dig Dis Sci. 2023 Jul 5. doi: 10.1007/s10620-023-07983.
    PubMed     Abstract available


  62. PATEL NB, Vinsard DG, Kattah AG, Kane SV, et al
    Decreased Risk of Preeclampsia in Women with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy.
    Dig Dis Sci. 2023 Jul 5. doi: 10.1007/s10620-023-08016.
    PubMed     Abstract available


  63. ESCKILSEN S, Kochar B, Weaver KN, Herfarth HH, et al
    Very Early Pouchitis Is Associated with an Increased Likelihood of Chronic Inflammatory Conditions of the Pouch.
    Dig Dis Sci. 2023;68:3139-3147.
    PubMed     Abstract available


  64. BIAN Z, Zhang Q, Qin Y, Sun X, et al
    Sodium Butyrate Inhibits Oxidative Stress and NF-kappaB/NLRP3 Activation in Dextran Sulfate Sodium Salt-Induced Colitis in Mice with Involvement of the Nrf2 Signaling Pathway and Mitophagy.
    Dig Dis Sci. 2023;68:2981-2996.
    PubMed     Abstract available


    June 2023
  65. VUYYURU SK, Solitano V, Hogan M, MacDonald JK, et al
    Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn's Disease: Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2023 Jun 28. doi: 10.1007/s10620-023-08014.
    PubMed     Abstract available


  66. TSE CS, Nguyen HP, Singh S, Dulai PS, et al
    Correlations Between Gastrointestinal Symptoms and Endoscopic-Histologic Disease Activity in Adults with Ulcerative Colitis.
    Dig Dis Sci. 2023 Jun 3. doi: 10.1007/s10620-023-07986.
    PubMed     Abstract available


  67. SALWEN-DEREMER JK, Godzik CM, Jagielski CH, Siegel CA, et al
    Patients with IBD Want to Talk About Sleep and Treatments for Insomnia with Their Gastroenterologist.
    Dig Dis Sci. 2023;68:2291-2302.
    PubMed     Abstract available


    May 2023
  68. KUANG R, Levinthal DJ, Ghaffari AA, Del Aguila de Rivers CR, et al
    Nightshade Vegetables: A Dietary Trigger for Worsening Inflammatory Bowel Disease and Irritable Bowel Syndrome?
    Dig Dis Sci. 2023 May 19. doi: 10.1007/s10620-023-07955.
    PubMed     Abstract available


  69. GOGOKHIA L, Lukin DJ
    PRO Tips: First-Rate Guidance for Second-Line Therapy After Tumor Necrosis Factor-Alpha Exposure in Patients with Crohn's Disease.
    Dig Dis Sci. 2023 May 5. doi: 10.1007/s10620-023-07941.
    PubMed    


  70. JANSEN FM, Smits LJT, Thomas PWA, de Jong DJ, et al
    Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy.
    Dig Dis Sci. 2023 May 2. doi: 10.1007/s10620-023-07950.
    PubMed     Abstract available


  71. KIM SY, Park JH, Leite G, Pimentel M, et al
    Interleukin-10 Knockout Mice Do Not Reliably Exhibit Macroscopic Inflammation: A Natural History Endoscopic Surveillance Study.
    Dig Dis Sci. 2023;68:1858-1862.
    PubMed     Abstract available


    April 2023
  72. WONG ECL, Merat S, Monaco C, Dulai PS, et al
    Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study.
    Dig Dis Sci. 2023 Apr 29. doi: 10.1007/s10620-023-07956.
    PubMed     Abstract available


  73. KAPPELMAN MD, Lewis JD, Zhang X, Lin FC, et al
    Comparing Patient-Reported Outcomes Among Anti-TNF-Experienced Patients with Crohn's Disease Initiating Vedolizumab Versus Ustekinumab.
    Dig Dis Sci. 2023 Apr 28. doi: 10.1007/s10620-023-07942.
    PubMed     Abstract available


  74. FANTASIA S, Cortegoso Valdivia P, Gaiani F
    Ileal Acute Diverticulitis Mimicking Crohn's Disease.
    Dig Dis Sci. 2023 Apr 28. doi: 10.1007/s10620-023-07954.
    PubMed    


  75. CHODEN T, Cohen RD
    Looking from the Past to the Future: How Janus Kinase Inhibitors Have Altered the Therapy of Ulcerative Colitis.
    Dig Dis Sci. 2023 Apr 8. doi: 10.1007/s10620-023-07933.
    PubMed    


  76. NELSON AD, Fluxa D, Caldera F, Farraye FA, et al
    Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Apr 7. doi: 10.1007/s10620-023-07920.
    PubMed     Abstract available


  77. DARLINGTON K, Googe P, Vedak P, Jain A, et al
    Lower Extremity Palpable Purpura in a Patient with Quiescent Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Apr 6. doi: 10.1007/s10620-023-07934.
    PubMed    


  78. ALMASRY M, Caldera F
    Taking a JAB at How Gastroenterologists Can Increase Vaccination Rates in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Apr 6. doi: 10.1007/s10620-023-07905.
    PubMed    


  79. PATEL J, Noureldin M, Fakhouri D, Farraye FA, et al
    Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2023 Apr 6. doi: 10.1007/s10620-023-07903.
    PubMed     Abstract available


  80. COHEN NA, Steinberg JM, Silfen A, Traboulsi C, et al
    Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes.
    Dig Dis Sci. 2023;68:1464-1472.
    PubMed     Abstract available


  81. LIANG C, Tang Y, Gao X, Lei N, et al
    Depression Exacerbates Dextran Sulfate Sodium-Induced Colitis via IRF5-Mediated Macrophage Polarization.
    Dig Dis Sci. 2023;68:1269-1279.
    PubMed     Abstract available


  82. RAJBHANDARI R, Blakemore S, Gupta N, Mannan S, et al
    Crohn's Disease Among the Poorest Billion: Burden of Crohn's Disease in Low- and Lower-Middle-Income Countries.
    Dig Dis Sci. 2023;68:1226-1236.
    PubMed     Abstract available


    March 2023
  83. NOSER AE, Lancaster BD, Hommel KA, Roberts CM, et al
    Use of Behavior Change Techniques and Quality of Commercially Available Inflammatory Bowel Disease Apps.
    Dig Dis Sci. 2023 Mar 18. doi: 10.1007/s10620-023-07884.
    PubMed     Abstract available


  84. DALAL RS, Goksel B, Hamilton MJ
    Excipient Exception: A Complication of Infliximab and Vedolizumab Infusions for Ulcerative Colitis.
    Dig Dis Sci. 2023 Mar 17. doi: 10.1007/s10620-023-07866.
    PubMed    


  85. ERIKSSON C, Soderling J, Karlqvist S, Broms G, et al
    Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease.
    Dig Dis Sci. 2023 Mar 17. doi: 10.1007/s10620-023-07897.
    PubMed     Abstract available


  86. UNGARO RC, Naegeli AN, Choong CK, Shan M, et al
    Early Use of Biologics Reduces Healthcare Costs in Crohn's Disease: Results from a United States Population-Based Cohort.
    Dig Dis Sci. 2023 Mar 15. doi: 10.1007/s10620-023-07906.
    PubMed     Abstract available


  87. STRAATMIJER T, Biemans VBC, Moes DJAR, Hoentjen F, et al
    Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn's Disease.
    Dig Dis Sci. 2023 Mar 15. doi: 10.1007/s10620-023-07822.
    PubMed     Abstract available


  88. LEVITTE S, Peale FV, Jhun I, McBride J, et al
    Local Pentraxin-2 Deficit Is a Feature of Intestinal Fibrosis in Crohn's Disease.
    Dig Dis Sci. 2023 Mar 8. doi: 10.1007/s10620-023-07909.
    PubMed     Abstract available


  89. AHMED T, Kayal M, Hashem D, Ungaro RC, et al
    Besting the Biologics: Vancomycin Monotherapy for Ulcerative Colitis Management in Patients with Primary Sclerosing Cholangitis.
    Dig Dis Sci. 2023 Mar 7. doi: 10.1007/s10620-023-07826.
    PubMed    


  90. VELAYOS FS
    Rise over Runs: Elevated Creatinine and a New Diagnosis of Inflammatory Bowel Disease.
    Dig Dis Sci. 2023 Mar 7. doi: 10.1007/s10620-023-07852.
    PubMed    


  91. CONSTANT BD, de Zoeten EF, Weinman JP, Albenberg L, et al
    Early Anti-Tumor-Necrosis-Factor Therapy for Crohn's Disease-Related Abdominal Abscesses and Phlegmon in Children.
    Dig Dis Sci. 2023;68:877-888.
    PubMed     Abstract available


  92. AGGARWAL M, Garg R, Parthasarthy G, Nowacki AS, et al
    Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:1006-1015.
    PubMed     Abstract available


  93. FRIEDBERG S, Hanan I, Hyman N, Rubio G, et al
    Ileal Desmoid Tumor in Ileal Crohn's: Coincidence or Connection?
    Dig Dis Sci. 2023;68:1071-1073.
    PubMed    


    February 2023
  94. MUBASHIR M, Carnell C, Haddadin I, Holubar SD, et al
    Refractory Ulcerative Colitis Requiring Preoperative Suction Thrombectomy of Submassive Bilateral Pulmonary Emboli Before Total Abdominal Colectomy.
    Dig Dis Sci. 2023 Feb 28. doi: 10.1007/s10620-023-07843.
    PubMed    


  95. BERINSTEIN EM, Sheehan JL, Jacob J, Steiner CA, et al
    Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the Literature.
    Dig Dis Sci. 2023 Feb 20:1-20. doi: 10.1007/s10620-023-07837.
    PubMed     Abstract available


  96. EVANS NS, Velayos FS
    On a Knife's Edge: Management of Vulvar Cutaneous Crohn's Disease.
    Dig Dis Sci. 2023 Feb 18. doi: 10.1007/s10620-022-07818.
    PubMed    


  97. PATEL PV, Kao E, Stekol E, Heyman MB, et al
    Evaluating the Relationship Between Nutrition and Post-colectomy Pouchitis in Pediatric Patients with Ulcerative Colitis.
    Dig Dis Sci. 2023 Feb 18. doi: 10.1007/s10620-023-07872.
    PubMed     Abstract available


  98. PANES J, Otley A, Sanchez Gonzalez Y, Fitzgerald K, et al
    Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis.
    Dig Dis Sci. 2023 Feb 11. doi: 10.1007/s10620-022-07807.
    PubMed     Abstract available


  99. WEINTRAUB Y, Cohen S, Anafy A, Chapnik N, et al
    Inverse Relationship Between Clock Gene Expression and Inflammatory Markers in Ulcerative Colitis Patients Undergoing Remission.
    Dig Dis Sci. 2023 Feb 6. doi: 10.1007/s10620-023-07847.
    PubMed     Abstract available


  100. LICHTENSTEIN GR, Cohen BL, Salese L, Modesto I, et al
    Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis.
    Dig Dis Sci. 2023 Feb 4. doi: 10.1007/s10620-022-07794.
    PubMed     Abstract available


  101. COHEN NA, Kliper E, Zamstein N, Ziv-Baran T, et al
    Trends in Biochemical Parameters, Healthcare Resource and Medication Use in the 5 Years Preceding IBD Diagnosis: A Health Maintenance Organization Cohort Study.
    Dig Dis Sci. 2023;68:414-422.
    PubMed     Abstract available


  102. IRWIN J, Lord A, Ferguson E, Simms LA, et al
    A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn's Disease.
    Dig Dis Sci. 2023;68:596-607.
    PubMed     Abstract available


  103. FABIAN O, Klocperk A, Lerchova T, Jencova P, et al
    Serum and Mucosal CD30 in Pediatric Inflammatory Bowel Diseases: Useful Biomarker for Diagnosis and Disease Activity Monitoring?
    Dig Dis Sci. 2023;68:460-470.
    PubMed     Abstract available


  104. BODECKER-ZINGMARK L, Widbom L, Hultdin J, Eriksson C, et al
    Anti-Saccharomyces cerevisiae Antibodies Are Only Modestly More Common in Subjects Later Developing Crohn's Disease.
    Dig Dis Sci. 2023;68:608-615.
    PubMed     Abstract available


  105. TAKAHASHI Y, Nagaya T, Iwaya Y, Okamura T, et al
    CD8(+) Lymphocyte Infiltration Is a Specific Feature of Colitis Induced by Immune Checkpoint Inhibitors.
    Dig Dis Sci. 2023;68:451-459.
    PubMed     Abstract available


  106. TRABOULSI C, Ayoub F, Silfen A, Rodriguez TG, et al
    Upadacitinib Is Safe and Effective for Crohn's Disease: Real-World Data from a Tertiary Center.
    Dig Dis Sci. 2023;68:385-388.
    PubMed     Abstract available


    January 2023
  107. NAM K, Lee JY, Ko Y, Kim KW, et al
    Impact of Sarcopenia on Clinical Course of Inflammatory Bowel Disease in Korea.
    Dig Dis Sci. 2023 Jan 24. doi: 10.1007/s10620-023-07838.
    PubMed     Abstract available


  108. YU J, Lv Y, Luo Y, Fang Y, et al
    One Case of Epstein-Barr Virus Encephalitis from Pediatric Crohn's Disease After 6-Mercaptopurine and Infliximab Treatment.
    Dig Dis Sci. 2023 Jan 21. doi: 10.1007/s10620-022-07801.
    PubMed    


  109. CANAKIS A, Kolachana S, Holden VK, Cross RK, et al
    Opportunistic Knocks: A Gardener with Ulcerative Colitis and New Pulmonary Nodules.
    Dig Dis Sci. 2023 Jan 21:1-5. doi: 10.1007/s10620-022-07785.
    PubMed    


  110. MALMQUIST M, Rabe H, Malmborg P, Gale G, et al
    Frequent Occurrence of Perianal Disease and Granuloma Formation in Patients with Crohn's Disease and Coexistent Orofacial Granulomatosis.
    Dig Dis Sci. 2023 Jan 16. doi: 10.1007/s10620-023-07821.
    PubMed     Abstract available


  111. NARULA N, Wong ECL, Dulai PS, Marshall JK, et al
    Vedolizumab and Adalimumab in Biologic-Naive Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission.
    Dig Dis Sci. 2023 Jan 16. doi: 10.1007/s10620-023-07825.
    PubMed     Abstract available


  112. SHEEHAN GT, Twardus SW, Cagan A, Ananthakrishnan AN, et al
    E-cigarette Use and Disease Outcomes in Inflammatory Bowel Diseases: A Case-Control Study.
    Dig Dis Sci. 2023;68:208-213.
    PubMed     Abstract available


  113. FORSS A, Clements M, Myrelid P, Strid H, et al
    Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease.
    Dig Dis Sci. 2023;68:65-76.
    PubMed     Abstract available


    December 2022
  114. CHUNG A, Carroll M, Almeida P, Petrova A, et al
    Early Infliximab Clearance Predicts Remission in Children with Crohn's Disease.
    Dig Dis Sci. 2022 Dec 23. doi: 10.1007/s10620-022-07783.
    PubMed     Abstract available


  115. SYAL G, Melmed GY, Almario CV, Spiegel BMR, et al
    Azathioprine Withdrawal Is Cost-Effective in Patients with Crohn's Disease in Remission on Infliximab and Azathioprine.
    Dig Dis Sci. 2022 Dec 13. doi: 10.1007/s10620-022-07789.
    PubMed     Abstract available


  116. MONGARDINI FM
    Author Spotlight: Federico Maria Mongardini.
    Dig Dis Sci. 2022;67:5433.
    PubMed    


  117. TURBAYNE AK, Sparrow MP
    Low-Dose Azathioprine in Combination with Allopurinol: The Past, Present and Future of This Useful Duo.
    Dig Dis Sci. 2022;67:5382-5391.
    PubMed     Abstract available


  118. PEYRIN-BIROULET L, Bouguen G, Laharie D, Pellet G, et al
    Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study.
    Dig Dis Sci. 2022;67:5637-5646.
    PubMed     Abstract available


  119. KAAZAN P, Tan Z, Maiyani P, Mickenbecker M, et al
    Weight and BMI Patterns in a Biologicals-Treated IBD Cohort.
    Dig Dis Sci. 2022;67:5628-5636.
    PubMed     Abstract available


  120. LEE KE, Lim F, Faye AS, Shen B, et al
    Endoscopic Balloon Dilation Is Cost-Effective for Crohn's Disease Strictures.
    Dig Dis Sci. 2022;67:5462-5471.
    PubMed     Abstract available


    November 2022
  121. GEBEYEHU GG, Fiske J, Liu E, Limdi JK, et al
    Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients.
    Dig Dis Sci. 2022 Nov 27:1-12. doi: 10.1007/s10620-022-07770.
    PubMed     Abstract available


  122. MARATT JK, Siegel CA, Barkun AN, Bouhnik Y, et al
    An Expert Consensus to Standardize Assessment of Bowel Cleansing for Clinical Trials of Bowel Preparations for Crohn's Disease.
    Dig Dis Sci. 2022 Nov 27. doi: 10.1007/s10620-022-07775.
    PubMed     Abstract available


  123. SHERRILL GC, Esckilsen S, Hudson J, Kochar B, et al
    Relationship Between Stages of Ileal Pouch-Anal Anastomosis, Timing of Restoration of Fecal Continuity, and Pouchitis.
    Dig Dis Sci. 2022;67:5220-5226.
    PubMed     Abstract available


  124. HERMAN HS, Rosenthaler MP, Elhassan N, Weinberg JM, et al
    COVID-19 Vaccine Hesitancy Among Patients with Inflammatory Bowel Diseases at a Diverse Safety Net Hospital.
    Dig Dis Sci. 2022;67:5029-5033.
    PubMed     Abstract available


  125. KOCHAR BD, Cheng D, Cai T, Ananthakrishnan AN, et al
    Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:5206-5212.
    PubMed     Abstract available


  126. SIEBER A, Aberra FN, Bonhomme B, McKeever L, et al
    Influence of Corticosteroid Use on Short- and Long-Term Outcomes of Biologic Therapy for Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:5168-5176.
    PubMed     Abstract available


    October 2022
  127. BARRETT CM, Long MD, Grimm I, Herfarth HH, et al
    Off the Cuff Markers: Surveillance and Endoscopic Approaches for Dysplasia After Ileal Pouch-Anal Anastomosis.
    Dig Dis Sci. 2022;67:4666-4670.
    PubMed    


  128. SULTAN K, Trindade AJ
    Concise Commentary: Is Splitting the Difference? Identifying Risk Factors Associated with Suboptimal Bowel Preparation for Colonoscopy Among IBD Patients.
    Dig Dis Sci. 2022;67:4602-4603.
    PubMed    


  129. ZAND A, Stokes Z, Sharma A, van Deen WK, et al
    Artificial Intelligence for Inflammatory Bowel Diseases (IBD); Accurately Predicting Adverse Outcomes Using Machine Learning.
    Dig Dis Sci. 2022;67:4874-4885.
    PubMed     Abstract available


  130. SIGALA-ROBLES R, Santiago-Lopez L, Hernandez-Mendoza A, Vallejo-Cordoba B, et al
    Peptides, Exopolysaccharides, and Short-Chain Fatty Acids from Fermented Milk and Perspectives on Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:4654-4665.
    PubMed     Abstract available


  131. SYAL G, Sparrow MP, Velayos F, Cheifetz AS, et al
    Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology.
    Dig Dis Sci. 2022;67:4687-4694.
    PubMed     Abstract available


  132. SUCHMAN K, Luo Y, Grinspan A
    Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort.
    Dig Dis Sci. 2022;67:4866-4873.
    PubMed     Abstract available


    September 2022
  133. MIYAZAKI H, Watanabe D, Ito Y, Okamoto N, et al
    Side Effects of COVID-19 Vaccines in Patients with Inflammatory Bowel Disease in Japan.
    Dig Dis Sci. 2022 Sep 30. pii: 10.1007/s10620-022-07703.
    PubMed     Abstract available


  134. SONNENBERG A
    Similar Time Trends of Hodgkin Lymphoma, Multiple Sclerosis, and Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Sep 27. pii: 10.1007/s10620-022-07705.
    PubMed     Abstract available


  135. ASHAT D, Jain A, Weaver KN, Long MD, et al
    An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2022 Sep 20. pii: 10.1007/s10620-022-07682.
    PubMed    


  136. CHODEN T, Yeager M, Cohen RD
    Checking Out the Associations Between Inflammatory Bowel Disease and Checkpoint Inhibitor Colitis.
    Dig Dis Sci. 2022 Sep 13. pii: 10.1007/s10620-022-07668.
    PubMed    


  137. SPENCER EA, Dolinger MT, Dubinsky MC
    A Single-Center Experience with Dupilumab for Atopic or Psoriasiform Dermatitis in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Sep 5. pii: 10.1007/s10620-022-07684.
    PubMed     Abstract available


  138. SINGH A, Midha V, Mahajan R, Verma S, et al
    Evaluation of Nutritional Characteristics Reveals Similar Prevalence of Malnutrition in Patients with Ulcerative Colitis and Crohn's Disease.
    Dig Dis Sci. 2022 Sep 5. pii: 10.1007/s10620-022-07652.
    PubMed     Abstract available


  139. DAI C, Jiang M, Huang YH
    Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy.
    Dig Dis Sci. 2022 Sep 5. pii: 10.1007/s10620-022-07648.
    PubMed    


  140. CHUGH R, Mahadevan U
    Advanced Fellowship Training in IBD: A Worthwhile Fourth Year.
    Dig Dis Sci. 2022;67:4339-4341.
    PubMed    


  141. HOLLANDER D
    DDS Perspective: Crohn's Disease and Increased Intestinal Permeability-Initial Demonstration and Birth Pains.
    Dig Dis Sci. 2022;67:4337-4338.
    PubMed    


  142. SUAREZ RG, Osornio-Vargas AR, Wine E
    Ambient Air Pollution and Pediatric Inflammatory Bowel Diseases: An Updated Scoping Review.
    Dig Dis Sci. 2022;67:4342-4354.
    PubMed     Abstract available


  143. BARNES EL
    Treating IBD? Don't Forget that Mental Health Matters.
    Dig Dis Sci. 2022;67:4321-4323.
    PubMed    


  144. ROSIOU K, Selinger CP
    Using the PIDA on Your PDA: Providing Personalized Education and Decision Support for Women with IBD of Childbearing Age.
    Dig Dis Sci. 2022;67:4315-4316.
    PubMed    


  145. DA SILVA MTB, Dos Santos AA
    Proinflammatory Effects of Wheat and Rye in an IBD Model: Give Us Not Our Daily Bread.
    Dig Dis Sci. 2022;67:4324-4325.
    PubMed    


  146. AVILA F, Caron B, Hossu G, Ambarki K, et al
    Magnetic Resonance Elastography for Assessing Fibrosis in Patients with Crohn's Disease: A Pilot Study.
    Dig Dis Sci. 2022;67:4518-4524.
    PubMed     Abstract available


    August 2022
  147. TEICH N, Stallmach A, Bruns T
    Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis.
    Dig Dis Sci. 2022 Aug 24. pii: 10.1007/s10620-022-07670.
    PubMed    


  148. WANG G, Tandon P, Rodriguez N, Ambrosio L, et al
    Impact of Disease Activity and Inflammatory Bowel Disease Subtype on Quality of Life in Preconception and Pregnant Patients.
    Dig Dis Sci. 2022 Aug 5. pii: 10.1007/s10620-022-07638.
    PubMed     Abstract available


  149. MAAS LA, Krishna M, Parian AM
    Ironing It All Out: A Comprehensive Review of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2022 Aug 5. pii: 10.1007/s10620-022-07599.
    PubMed     Abstract available


  150. KOUNTOURAS J, Papaefthymiou A, Polyzos SA, Liatsos C, et al
    Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Aug 5. pii: 10.1007/s10620-022-07642.
    PubMed    


  151. UZZAN M
    Tofacitinib: A Small Molecule for Biologic-Refractory Crohn's Disease?
    Dig Dis Sci. 2022;67:3479-3480.
    PubMed    


  152. LEE SD, Singla A, Harper J, Barahimi M, et al
    Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn's Disease.
    Dig Dis Sci. 2022;67:4043-4048.
    PubMed     Abstract available


  153. FLESHNER PR
    Concise Commentary: Crystallomancy and Ileal Pouch Surgery.
    Dig Dis Sci. 2022;67:4032.
    PubMed    


  154. GIRI S, Sundaram S
    Low Dose Azathioprine with Allopurinol in IBD: Early Days to Call It a Recipe for Success.
    Dig Dis Sci. 2022;67:4263-4265.
    PubMed    


  155. VAN LIERE ELSA, Bayoumy AB, Mulder CJJ, Warner B, et al
    Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:4008-4019.
    PubMed     Abstract available


  156. LINDHOLM M, Di Sabatino A, Manon-Jensen T, Mazza G, et al
    A Serological Biomarker of Laminin Gamma 1 Chain Degradation Reflects Altered Basement Membrane Remodeling in Crohn's Disease and DSS Colitis.
    Dig Dis Sci. 2022;67:3662-3671.
    PubMed     Abstract available


  157. DASHARATHY SS, Limketkai BN, Sauk JS
    What's New in the Postoperative Management of Crohn's Disease?
    Dig Dis Sci. 2022;67:3508-3517.
    PubMed     Abstract available


    July 2022
  158. DAI C, Jiang M, Huang YH
    Neutrophil-to-Lymphocyte Ratio for the Diagnosis and Monitoring of Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Jul 22. pii: 10.1007/s10620-022-07593.
    PubMed    


  159. SELINGER CP
    Introduction to the DDS MiniIssue: "Inflammatory Bowel Disease and Pregnancy".
    Dig Dis Sci. 2022 Jul 13. pii: 10.1007/s10620-022-07603.
    PubMed    


  160. COHEN NA, Zafer M, Setia N, Anderson MJ, et al
    Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2022 Jul 4. pii: 10.1007/s10620-022-07607.
    PubMed     Abstract available


  161. PICETTI D, Kim J, Zhu W, Sandborn WJ, et al
    No Benefit of Continuing 5-Aminosalicylates in Patients with Crohn's Disease Treated with Anti-metabolite Therapy.
    Dig Dis Sci. 2022;67:3115-3123.
    PubMed     Abstract available


  162. HONAP S, Sharma E, Samaan MA
    5-ASAs in Crohn's Disease: Time to Stop the Salicylate?
    Dig Dis Sci. 2022;67:2699-2700.
    PubMed    


  163. AFIF W, Sattin B, Dajnowiec D, Khanna R, et al
    Ustekinumab Therapeutic Drug Monitoring-Impact on Clinical Practice: A Multicenter Cross-Sectional Observational Trial.
    Dig Dis Sci. 2022;67:3148-3157.
    PubMed     Abstract available


  164. OIZUMI T, Mayanagi T, Toya Y, Sugai T, et al
    NLRP3 Inflammasome Inhibitor OLT1177 Suppresses Onset of Inflammation in Mice with Dextran Sulfate Sodium-Induced Colitis.
    Dig Dis Sci. 2022;67:2912-2921.
    PubMed     Abstract available


  165. KOSTEV K, Loosen S, Roderburg C
    Prevalence of Hospitalization and Readmission in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:3471.
    PubMed    


  166. SINGH G, Haileselassie Y, Ji AR, Maecker HT, et al
    Protective Effect of Saffron in Mouse Colitis Models Through Immune Modulation.
    Dig Dis Sci. 2022;67:2922-2935.
    PubMed     Abstract available


  167. PABLA BS, Alex Wiles C, Slaughter JC, Scoville EA, et al
    Safety and Efficacy of Vedolizumab Versus Tumor Necrosis Factor alpha Antagonists in an Elderly IBD Population: A Single Institution Retrospective Experience.
    Dig Dis Sci. 2022;67:3129-3137.
    PubMed     Abstract available


  168. NAKASHIMA T, Fujii K, Seki T, Aoyama M, et al
    Novel Gut Microbiota Modulator, Which Markedly Increases Akkermansia muciniphila Occupancy, Ameliorates Experimental Colitis in Rats.
    Dig Dis Sci. 2022;67:2899-2911.
    PubMed     Abstract available


  169. GARG R, Aggarwal M, Butler R, Achkar JP, et al
    Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn's Disease Patients.
    Dig Dis Sci. 2022;67:3138-3147.
    PubMed     Abstract available


  170. SASSON AN, Ananthakrishnan AN
    High Anti-Infliximab Antibody Titers Do Not Impact Response to Subsequent Adalimumab Treatment in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:3124-3128.
    PubMed     Abstract available


    June 2022
  171. GU D, Cao T, Yi S, Liu Y, et al
    CCCTC-Binding Factor Mediates the Transcription of Insulin-Like Growth Factor Binding Protein 5 Through EZH2 in Ulcerative Colitis.
    Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07566.
    PubMed     Abstract available


  172. BARNES A, Ooi SJ, Lynch KD, Parthasarathy N, et al
    Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07556.
    PubMed     Abstract available


  173. KUMAR A, Swaminath A
    Impatience with Inpatients: Are Hospitalization Rates Declining for IBD Patients?
    Dig Dis Sci. 2022;67:1927-1929.
    PubMed    


  174. NGUYEN NH, Zhang X, Long MD, Sandborn WJ, et al
    Patient-Reported Outcomes and Risk of Hospitalization and Readmission in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:2039-2048.
    PubMed     Abstract available


  175. GORDON H, Blad W, Trier Moller F, Orchard T, et al
    UK IBD Twin Registry: Concordance and Environmental Risk Factors of Twins with IBD.
    Dig Dis Sci. 2022;67:2444-2450.
    PubMed     Abstract available


  176. ROCCHI C, Soliman YY, Massidda M, Vadala di Prampero SF, et al
    Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review.
    Dig Dis Sci. 2022;67:1948-1955.
    PubMed     Abstract available


  177. SINGH S, Heien HC, Sangaralingham L, Shah ND, et al
    Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-alpha Antagonists in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:2510-2516.
    PubMed     Abstract available


  178. SERVAIS L, Boschetti G, Meunier C, Gay C, et al
    Intestinal Conventional Ultrasonography, Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography in Assessment of Crohn's Disease Activity: A Comparison with Surgical Histopathology Analysis.
    Dig Dis Sci. 2022;67:2492-2502.
    PubMed     Abstract available


  179. WATANABE Y, Mizushima T, Okumura R, Fujino S, et al
    Fecal Stream Diversion Changes Intestinal Environment, Modulates Mucosal Barrier, and Attenuates Inflammatory Cells in Crohn's Disease.
    Dig Dis Sci. 2022;67:2143-2157.
    PubMed     Abstract available


  180. COSTABLE NJ, Borman ZA, Ji J, Dubinsky MC, et al
    Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab.
    Dig Dis Sci. 2022;67:2480-2484.
    PubMed     Abstract available


  181. XIE M, Xiong Z, Yin S, Xiong J, et al
    Adiponectin Alleviates Intestinal Fibrosis by Enhancing AMP-Activated Protein Kinase Phosphorylation.
    Dig Dis Sci. 2022;67:2232-2243.
    PubMed     Abstract available


    May 2022
  182. ZHANG M, Xie Z, Zhou G, Wang Y, et al
    Conflicting Effects of Wnt-5a in Ulcerative Colitis: You Wnt Some, You Lose Some.
    Dig Dis Sci. 2022 May 31. pii: 10.1007/s10620-022-07542.
    PubMed    


  183. KUMAR A, Shenoy V, Buckley MC, Durbin L, et al
    Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy.
    Dig Dis Sci. 2022 May 27. pii: 10.1007/s10620-022-07530.
    PubMed     Abstract available


  184. UCHIYAMA K, Takagi T, Mizushima K, Asaeda K, et al
    Investigation on the Inhibitory Effect of Wnt-5a on Colonic Mucosal Inflammation in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2022 May 19. pii: 10.1007/s10620-022-07537.
    PubMed     Abstract available


  185. GOTTLIEB ZS, Dolinger M, Kayal M, Rao BB, et al
    Clinical Challenge: Proactive Precise Management of Active Ulcerative Colitis During Pregnancy-Advantages of Point-of-Care Intestinal Ultrasound and Therapeutic Drug Monitoring.
    Dig Dis Sci. 2022 May 17. pii: 10.1007/s10620-022-07532.
    PubMed    


  186. SIMSEK-ONAT P, Hizarcioglu-Gulsen H, Ergen YM, Gumus E, et al
    Neutrophil-to-Lymphocyte Ratio: An Easy Marker for the Diagnosis and Monitoring of Inflammatory Bowel Disease in Children.
    Dig Dis Sci. 2022 May 17. pii: 10.1007/s10620-022-07547.
    PubMed     Abstract available


  187. BUERKLE KS, Vernon-Roberts A, Ho C, Schultz M, et al
    A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 May 5. pii: 10.1007/s10620-022-07507.
    PubMed     Abstract available


  188. HILL E, Nguyen NH, Qian AS, Patel S, et al
    Impact of Comorbid Psychiatric Disorders on Healthcare Utilization in Patients with Inflammatory Bowel Disease: A Nationally Representative Cohort Study.
    Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07505.
    PubMed     Abstract available


  189. CON D, Vasudevan A
    Real-World Guidance from Artificial Intelligence? Predicting Outcomes of Inflammatory Bowel Disease Using Machine Learning.
    Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07511.
    PubMed    


  190. BRENNER EJ, Long MD, Kappelman MD, Zhang X, et al
    Development of an Inflammatory Bowel Disease-Specific Medication Adherence Instrument and Reasons for Non-adherence.
    Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07517.
    PubMed     Abstract available


  191. GEORGOPOULOS I, Mavrigiannaki E, Stasinopoulou S, Renieris G, et al
    Experimental Intestinal Stenosis Alters Crohn's Disease-Like Intestinal Inflammation in Ileitis-Prone Mice.
    Dig Dis Sci. 2022;67:1783-1793.
    PubMed     Abstract available


    April 2022
  192. WANG G, Karimi N, Willmann L, Pipicella J, et al
    A Novel Decision Aid Improves Quality of Reproductive Decision-Making and Pregnancy Knowledge for Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Apr 30. pii: 10.1007/s10620-022-07494.
    PubMed     Abstract available


  193. FAN Y, Delgado-Aros S, Valdecantos WC, Janak JC, et al
    Characteristics of Patients with Crohn's Disease With or Without Perianal Fistulae in the CorEvitas Inflammatory Bowel Disease Registry.
    Dig Dis Sci. 2022 Apr 25. pii: 10.1007/s10620-022-07491.
    PubMed     Abstract available


  194. DALAL RS, McClure EL, Marcus J, Allegretti JR, et al
    Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naive Patients with Ulcerative Colitis.
    Dig Dis Sci. 2022 Apr 12. pii: 10.1007/s10620-022-07472.
    PubMed     Abstract available


  195. EMERSON C, Skvarc D, Fuller-Tyszkiewicz M, Olive L, et al
    Self-Worth Beliefs Predict Willingness to Engage in Psychotherapy for Fatigue in Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Apr 8. pii: 10.1007/s10620-022-07476.
    PubMed     Abstract available


  196. CAPLAN A, McConnell R, Velayos F, Mahadevan U, et al
    Delayed Initiation of Rescue Therapy Associated with Increased Length of Stay in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2022 Apr 7. pii: 10.1007/s10620-022-07490.
    PubMed     Abstract available


  197. DE JONG ME, Nagtegaal ID, Vos S, van der Post RS, et al
    Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia.
    Dig Dis Sci. 2022 Apr 5. pii: 10.1007/s10620-022-07485.
    PubMed     Abstract available


  198. MACEDO SILVA V, Freitas M, Boal Carvalho P, Dias de Castro F, et al
    Apex Score: Predicting Flares in Small-Bowel Crohn's Disease After Mucosal Healing.
    Dig Dis Sci. 2022;67:1278-1286.
    PubMed     Abstract available


  199. TSIAOUSSIS GI, Christaki E
    Is the APEX Score the Pinnacle of Predictive Scoring Systems of Disease Flare in Crohn's Patients with Documented Mucosal Healing?
    Dig Dis Sci. 2022;67:1092-1094.
    PubMed    


  200. HORST S
    Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?
    Dig Dis Sci. 2022;67:1090-1091.
    PubMed    


  201. DAI C, Huang YH
    Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery.
    Dig Dis Sci. 2022;67:1421-1422.
    PubMed    


  202. LEE HS, Chiorean MV, Boden E, Lord J, et al
    Usefulness of Fluoroscopy for Endoscopic Balloon Dilation of Crohn's Disease-Related Strictures.
    Dig Dis Sci. 2022;67:1295-1302.
    PubMed     Abstract available


    March 2022
  203. DEKA D, D'Inca R, Sturniolo GC, Das A, et al
    Role of ER Stress Mediated Unfolded Protein Responses and ER Stress Inhibitors in the Pathogenesis of Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Mar 22. pii: 10.1007/s10620-022-07467.
    PubMed     Abstract available


  204. SASSON G, Kirby CH, Hamilton MJ, Winter RW, et al
    Serving Up a Mediterranean Remission in Severe Ulcerative Colitis.
    Dig Dis Sci. 2022 Mar 19. pii: 10.1007/s10620-022-07447.
    PubMed    


  205. SLEUTJES JAM, Roeters van Lennep JE, de Vries AC
    Spotlight on Cardiovascular Risk Assessment in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Mar 18. pii: 10.1007/s10620-022-07449.
    PubMed    


  206. AJBAR A, Cross E, Matoi S, Hay CA, et al
    Diagnostic Delay in Pediatric Inflammatory Bowel Disease: A Systematic Review.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07452.
    PubMed     Abstract available


  207. CORCORAN RM, MacDonagh P, O'Connell F, Morrissey ME, et al
    Association Between Ex Vivo Human Ulcerative Colitis Explant Protein Secretion Profiles and Disease Behaviour.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07411.
    PubMed     Abstract available


  208. AKIYAMA S, Ollech JE, Traboulsi C, Rai V, et al
    Histopathology of Colectomy Specimens Predicts Endoscopic Pouch Phenotype in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07405.
    PubMed     Abstract available


  209. AKIYAMA S, Cohen NA, Steinberg JM, Friedberg S, et al
    Rare and Well Done: Endoscopic Control of Colonic Hemorrhage in Severe Ulcerative Colitis.
    Dig Dis Sci. 2022 Mar 7. pii: 10.1007/s10620-022-07446.
    PubMed    


  210. XIAO Y, Benoit N, Sedano R, Jairath V, et al
    Effectiveness of Tofacitinib for Hospitalized Patients with Acute Severe Ulcerative Colitis: Case Series.
    Dig Dis Sci. 2022 Mar 4. pii: 10.1007/s10620-022-07439.
    PubMed     Abstract available


  211. GUILLO L, Amiot A, Serrero M, Altwegg R, et al
    Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study.
    Dig Dis Sci. 2022 Mar 4. pii: 10.1007/s10620-022-07445.
    PubMed     Abstract available


  212. YU Y, Zhao H, Luo Y, Lou J, et al
    Poor Concordance Between Clinical Activity and Endoscopic Severity in Pediatric Crohn's Disease: Before and After Induction Therapy.
    Dig Dis Sci. 2022;67:997-1006.
    PubMed     Abstract available


  213. YI Y, Sossenheimer PH, Erondu AI, Skowron KB, et al
    Using Wearable Biosensors to Predict Length of Stay for Patients with IBD After Bowel Surgery.
    Dig Dis Sci. 2022;67:844-853.
    PubMed     Abstract available


    February 2022
  214. WU RY, Tandon P, Ambrosio L, Dunsmore G, et al
    Post-neonatal Outcomes of Infants Born to Women with Active Trimester One Inflammatory Bowel Disease: A Pilot Study.
    Dig Dis Sci. 2022 Feb 24. pii: 10.1007/s10620-022-07430.
    PubMed     Abstract available


  215. FUJIYA M, Kawaguchi T, Arai S, Isogawa N, et al
    Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Feb 12. pii: 10.1007/s10620-022-07388.
    PubMed     Abstract available


  216. PEMMASANI G, Loftus EV, Tremaine WJ
    Prevalence of Pulmonary Diseases in Association with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Feb 10. pii: 10.1007/s10620-022-07385.
    PubMed     Abstract available


  217. FAYE AS
    Connecting the Dots: IBD and Frailty.
    Dig Dis Sci. 2022;67:406-407.
    PubMed    


  218. HUDHUD D, Stashek K, George L, Cross RK, et al
    An Adalimumab-Induced Mucosal Red Storm in a Patient with Crohn's Disease.
    Dig Dis Sci. 2022;67:453-456.
    PubMed    


  219. SHARMA N, Savelkoul E, Disney B, Shah A, et al
    A Multicenter Study of Patient Acceptability of the IBD Disk Tool and Patient-Reported Disabilities.
    Dig Dis Sci. 2022;67:457-462.
    PubMed     Abstract available


  220. HANZEL J, Almradi A, Istl AC, Yang ML, et al
    Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery: Meta-Analysis.
    Dig Dis Sci. 2022;67:646-660.
    PubMed     Abstract available


    January 2022
  221. KIM SH, Park Y, Kim SP, Lee SH, et al
    Shift to a Younger Age and Regional Differences in Inflammatory Bowel Disease in Korea: Using Healthcare Administrative Data.
    Dig Dis Sci. 2022 Jan 30. pii: 10.1007/s10620-021-07328.
    PubMed     Abstract available


  222. CLARKE K, Pelton M, Stuart A, Tinsley A, et al
    COVID-19 Vaccine Hesitancy in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Jan 29. pii: 10.1007/s10620-021-07377.
    PubMed     Abstract available


  223. KOBAYASHI M, Yamashita R, Ichikawa R, Shibutani M, et al
    Ectopically Localized Epithelial Cell Clumps in Ulcers Are Derived from Reserved Crypt Stem Cells in a Mouse Model of Ulcerative Colitis.
    Dig Dis Sci. 2022 Jan 28. pii: 10.1007/s10620-021-07340.
    PubMed     Abstract available


  224. VELAYOS FS, Lee JK
    Endoscopic Surveillance and Dysplasia Management in IBD: Plus Ca Change, Plus C'est la Meme Chose.
    Dig Dis Sci. 2022;67:81-84.
    PubMed    


  225. LITTLE RD, Chu IE, Ward MG, Sparrow MP, et al
    De-escalation from Dose-Intensified Anti-TNF Therapy Is Successful in the Majority of IBD Patients at 12 Months.
    Dig Dis Sci. 2022;67:259-262.
    PubMed     Abstract available


  226. SHIGA H, Abe I, Kusaka J, Shimoyama Y, et al
    Capsule Endoscopy Is Useful for Postoperative Tight Control Management in Patients with Crohn's Disease.
    Dig Dis Sci. 2022;67:263-272.
    PubMed     Abstract available


    December 2021
  227. HONG SJ, Katz S
    Frailty, Thy Diagnosis Is Uncertain: Impact on IBD Readmission and Mortality.
    Dig Dis Sci. 2021;66:4070-4071.
    PubMed    


  228. VEYRE F, Boschetti G, Meunier C, Cuerq C, et al
    Low Levels of Fecal Calprotectin 3 Months After Surgery Predict Subsequent Endoscopic Postoperative Remission in Crohn's Disease.
    Dig Dis Sci. 2021;66:4429-4435.
    PubMed     Abstract available


  229. FAYE AS, Wen T, Soroush A, Ananthakrishnan AN, et al
    Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBD.
    Dig Dis Sci. 2021;66:4178-4190.
    PubMed     Abstract available


    November 2021
  230. DOU D, Ji Y, Zheng J, Li J, et al
    A New Role for Conivaptan in Ulcerative Colitis in Mice: Inhibiting Differentiation of CD4(+)T Cells into Th1 Cells.
    Dig Dis Sci. 2021 Nov 9. pii: 10.1007/s10620-021-07300.
    PubMed     Abstract available


  231. LU J, Liu D, Tan Y, Li R, et al
    Thalidomide Attenuates Colitis and Is Associated with the Suppression of M1 Macrophage Polarization by Targeting the Transcription Factor IRF5.
    Dig Dis Sci. 2021;66:3803-3812.
    PubMed     Abstract available


  232. HONG SJ, Jang J, Berg D, Kirat T, et al
    Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes.
    Dig Dis Sci. 2021;66:3753-3759.
    PubMed     Abstract available


    October 2021
  233. XU F, Carlson SA, Liu Y, Greenlund KJ, et al
    Urban-Rural Differences in Health Care Utilization for Inflammatory Bowel Disease in the USA, 2017.
    Dig Dis Sci. 2021 Oct 11. pii: 10.1007/s10620-021-07264.
    PubMed     Abstract available


  234. RABINOWITZ LG, Zylberberg HM, Yang J, Gold SL, et al
    De Novo Ostomy Placement Is Associated with Increased Outpatient Opioid Use In Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Oct 6. pii: 10.1007/s10620-021-07257.
    PubMed     Abstract available


  235. RAKOWSKY ST, Feuerstein JD
    Highs and Lows of Proactive Therapeutic Drug Monitoring in Crohn's Patients.
    Dig Dis Sci. 2021;66:3226-3227.
    PubMed    


  236. LUO Y, Cheng Q, Fang Y, Yu J, et al
    Infliximab Therapy in Very Early Onset Crohn's Disease: Real-World Experience in China.
    Dig Dis Sci. 2021;66:3555-3562.
    PubMed     Abstract available


  237. ZHANG J, Li Y, Diao Y, Da B, et al
    Long-Term Outcome of Endoscopic Balloon Dilation for Duodenal Crohn's Disease-Associated Strictures.
    Dig Dis Sci. 2021;66:3570-3577.
    PubMed     Abstract available


  238. YARUR AJ, Deepak P, Vande Casteele N, Battat R, et al
    Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2021;66:3563-3569.
    PubMed     Abstract available


  239. BORREN NZ, Paulides E, Frinack JL, Olson RN, et al
    Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort Study.
    Dig Dis Sci. 2021;66:3548-3554.
    PubMed     Abstract available


    September 2021
  240. SELINGER CP, Rafferty H, Mooney P, Donnellan C, et al
    Utility of Fecal Calprotectin in Routine Clinical Practice Is Impaired by Poor Sample Return Rates.
    Dig Dis Sci. 2021;66:3209-3210.
    PubMed    


  241. JEON Y, Limketkai BN
    Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
    Dig Dis Sci. 2021;66:2853-2854.
    PubMed    


  242. DE SA BRITO FROES R, da Luz Moreira A, Carneiro AJV, Moreira JPL, et al
    Prevalence, Indirect Costs, and Risk Factors for Work Disability in Patients with Crohn's Disease at a Tertiary Care Center in Rio de Janeiro.
    Dig Dis Sci. 2021;66:2925-2934.
    PubMed     Abstract available


  243. ZHANG B, Su X, Xie Z, Ding H, et al
    Inositol-Requiring Kinase 1 Regulates Apoptosis via Inducing Endoplasmic Reticulum Stress in Colitis Epithelial Cells.
    Dig Dis Sci. 2021;66:3015-3025.
    PubMed     Abstract available


  244. KIM JY, Park SH, Park JC, Noh S, et al
    The Clinical Significance of Anastomotic Ulcers After Ileocolic Resection to Predict Postoperative Recurrence of Crohn's Disease.
    Dig Dis Sci. 2021;66:3132-3140.
    PubMed     Abstract available


  245. ZEZE K, Hirano A, Torisu T, Esaki M, et al
    Adding Thiopurine After Loss of Response to Infliximab Versus Early Combination in Treating Crohn's Disease: A Retrospective Study.
    Dig Dis Sci. 2021;66:3124-3131.
    PubMed     Abstract available


  246. VARMA S, Faye AS, Kannan A, Lawlor G, et al
    Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.
    Dig Dis Sci. 2021;66:3113-3123.
    PubMed     Abstract available


    August 2021
  247. JAMPALA N, Jain A, Herfarth HH, Long MD, et al
    Personalized Best: Toward Improving Care in Ulcerative Colitis.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07221.
    PubMed    


  248. SATO M, Fujii K, Takagi H, Shibuya I, et al
    Antibacterial and Immunosuppressive Effects of OPS-2071, a Candidate Therapy for Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07237.
    PubMed     Abstract available


  249. ISHIDA N, Miyazu T, Tamura S, Tani S, et al
    Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 Aug 30. pii: 10.1007/s10620-021-07233.
    PubMed     Abstract available


  250. KAYAL M, Bhagya Rao B, Bhattacharya A, Ungaro R, et al
    Clinical Challenge: From Ulcerative Colitis to Crohn's Disease-Like Pouch Inflammation.
    Dig Dis Sci. 2021 Aug 20. pii: 10.1007/s10620-021-07220.
    PubMed    


  251. DAI C, Jiang M, Huang YH
    COVID-19 Vaccination in Patients with Inflammatory Bowel Disease: A Survey from China.
    Dig Dis Sci. 2021 Aug 19. pii: 10.1007/s10620-021-07169.
    PubMed    


  252. GUERRERO VINSARD D, Karagozian R, Wakefield DB, Kane SV, et al
    Maternal Outcomes and Pregnancy-Related Complications Among Hospitalized Women with Inflammatory Bowel Disease: Report from the National Inpatient Sample.
    Dig Dis Sci. 2021 Aug 18. pii: 10.1007/s10620-021-07210.
    PubMed     Abstract available


  253. TSAI L, Nguyen NH, Ma C, Prokop LJ, et al
    Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn's Disease in Population-Based Cohort Studies.
    Dig Dis Sci. 2021 Aug 11. pii: 10.1007/s10620-021-07200.
    PubMed     Abstract available


  254. PARRA RS, da Rocha JJR, Feres O
    Growth Delay in Inflammatory Bowel Diseases: The Importance of Surgery.
    Dig Dis Sci. 2021;66:2840-2841.
    PubMed    


  255. HOU JK
    Antibiotics for Crohn's Disease: What Are We Treating?
    Dig Dis Sci. 2021;66:2478-2480.
    PubMed    


  256. PROCTOR DD
    DDS Perspective: Deborah D. Proctor, MD.
    Dig Dis Sci. 2021;66:2489-2492.
    PubMed    


  257. PROCTOR DD
    DDS Profile: Deborah D. Proctor, MD.
    Dig Dis Sci. 2021;66:2486-2488.
    PubMed    


  258. PAUL S, Williet N, Nancey S, Veyrard P, et al
    No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification.
    Dig Dis Sci. 2021;66:2744-2749.
    PubMed     Abstract available


  259. ALIBAZ-ONER F, Ergelen R, Ergenc I, Seven G, et al
    Femoral Vein Wall Thickness Measurement May Be a Distinctive Diagnostic Tool to Differentiate Behcet's Disease with Intestinal Involvement and Crohn's Disease.
    Dig Dis Sci. 2021;66:2750-2755.
    PubMed     Abstract available


  260. SHPOLIANSKY M, Roggenbuck D, Pinsker M, Salamon N, et al
    Antibodies Against Glycoprotein 2 Are Specific Biomarkers for Pediatric Crohn's Disease.
    Dig Dis Sci. 2021;66:2619-2626.
    PubMed     Abstract available


  261. DA COSTA FERREIRA S, Sadissou IA, Parra RS, Feitosa MR, et al
    Increased HLA-G Expression in Tissue-Infiltrating Cells in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2021;66:2610-2618.
    PubMed     Abstract available


  262. CHATEAU T, Damico F, Zallot C, Mathieu N, et al
    Crohn's Disease Only Visible on Small Bowel Capsule Endoscopy: A New Entity.
    Dig Dis Sci. 2021;66:2712-2716.
    PubMed     Abstract available


  263. RHODES JM, Subramanian S, Flanagan PK, Horgan GW, et al
    Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's Disease.
    Dig Dis Sci. 2021;66:2700-2711.
    PubMed     Abstract available


    July 2021
  264. SALWEN-DEREMER JK, Smith MT, Haskell HG, Schreyer C, et al
    Poor Sleep in Inflammatory Bowel Disease Is Reflective of Distinct Sleep Disorders.
    Dig Dis Sci. 2021 Jul 30. pii: 10.1007/s10620-021-07176.
    PubMed     Abstract available


  265. NARULA N, Hu A, Nguyen GC, Rangrej J, et al
    Periodic Colonoscopies Are Associated with Improved Survival and Prognosis of Colorectal Cancer in Ulcerative Colitis.
    Dig Dis Sci. 2021 Jul 27. pii: 10.1007/s10620-021-07151.
    PubMed     Abstract available


  266. STEWART MJ
    Does Surveillance Increase Survival? Benefits of Periodic Colonoscopy in Patients with Ulcerative Colitis and Colorectal Cancer.
    Dig Dis Sci. 2021 Jul 27. pii: 10.1007/s10620-021-07174.
    PubMed    


  267. HEATH EM, Kim RB, Wilson A
    A Comparative Analysis of Drug Therapy, Disease Phenotype, and Health Care Outcomes for Men and Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jul 27. pii: 10.1007/s10620-021-07177.
    PubMed     Abstract available


  268. GOLOVICS PA, Gonczi L, Reinglas J, Verdon C, et al
    Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study.
    Dig Dis Sci. 2021 Jul 20. pii: 10.1007/s10620-021-07178.
    PubMed     Abstract available


  269. KIM ES, Kim KO, Jang BI, Kim EY, et al
    Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2021 Jul 14. pii: 10.1007/s10620-021-07130.
    PubMed     Abstract available


  270. RAO S, Borum ML
    Evaluating IBD Patient-Initiated Electronic Communication During the SARS-CoV-2 Pandemic: A Single-Center Study.
    Dig Dis Sci. 2021;66:2468-2469.
    PubMed    


  271. DALAL RS, Lichtenstein GR
    Superiority Complex: Do Teaching Hospitals Provide Inferior Care for IBD Patients?
    Dig Dis Sci. 2021;66:2137-2139.
    PubMed    


  272. HUDHUD D, Zhu G, Twaddell W, Bafford A, et al
    "Sarc" Attack: Rectal Bleeding in an Elderly Patient with Small Bowel Crohn's Disease.
    Dig Dis Sci. 2021;66:2190-2193.
    PubMed    


  273. CALABRESE C, Dussias N, Impellizzeri G, Lauro A, et al
    CEing More-Assessing Small Bowel Crohn's with Capsule Endoscopy (CE).
    Dig Dis Sci. 2021;66:2173-2176.
    PubMed     Abstract available


    June 2021
  274. PAULIDES E, Pasma A, Erler NS, van Eijk RLA, et al
    Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07118.
    PubMed     Abstract available


  275. PAREKH R, Zhang X, Ungaro RC, Brenner EJ, et al
    Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07104.
    PubMed     Abstract available


  276. BHAT S, Limdi JK, Cross RK, Farraye FA, et al
    Does Similarity Breed Contempt? A Review of the Use of Biosimilars in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07114.
    PubMed     Abstract available


  277. GRANDMOUGIN A, D'Amico F, Remen T, Danese S, et al
    Role of Cross-Sectional Imaging in Pediatric Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 22. pii: 10.1007/s10620-021-07016.
    PubMed     Abstract available


  278. FAWSON S, Dibley L, Smith K, Batista J, et al
    Developing an Online Program for Self-Management of Fatigue, Pain, and Urgency in Inflammatory Bowel Disease: Patients' Needs and Wants.
    Dig Dis Sci. 2021 Jun 19. pii: 10.1007/s10620-021-07109.
    PubMed     Abstract available


  279. STONE ML, Feng M, Forster EM
    COVID-19 Pandemic Increased Anxiety Among Patients with Inflammatory Bowel Disease: A Patient Survey in a Tertiary Referral Center.
    Dig Dis Sci. 2021 Jun 11. pii: 10.1007/s10620-021-07095.
    PubMed     Abstract available


  280. MCCURDY JD, Ellen Kuenzig M, Spruin S, Fung OW, et al
    Surgery and the Subtype of Inflammatory Bowel Disease Impact the Risk of Venous Thromboembolism After Hospital Discharge.
    Dig Dis Sci. 2021 Jun 10. pii: 10.1007/s10620-021-07064.
    PubMed     Abstract available


  281. ISHIHARA J, Arai K, Kudo T, Nambu R, et al
    Serum Zinc and Selenium in Children with Inflammatory Bowel Disease: A Multicenter Study in Japan.
    Dig Dis Sci. 2021 Jun 8. pii: 10.1007/s10620-021-07078.
    PubMed     Abstract available


  282. JEON Y, Leung D, Lis CA, Wang HL, et al
    Casting a Wider NET: Is It Crohn's or Is It Neuroendocrine Tumor?
    Dig Dis Sci. 2021;66:1802-1806.
    PubMed    


  283. ARMSTRONG J, Sarhan S
    Observations on the Effect of Electronic Needle Container on Adherence to Adalimumab.
    Dig Dis Sci. 2021;66:2135-2136.
    PubMed    


  284. ABOUBAKR A, Riggs AR, Jimenez D, Mella MT, et al
    Identifying Patient Priorities for Preconception and Pregnancy Counseling in IBD.
    Dig Dis Sci. 2021;66:1829-1835.
    PubMed     Abstract available


    May 2021
  285. EMERSON C, Fuller-Tyszkiewicz M, Orr R, Lyall K, et al
    Low Subjective Wellbeing Is Associated with Psychological Distress in People Living with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 May 29. pii: 10.1007/s10620-021-07065.
    PubMed     Abstract available


  286. AL KHOURY A, Balram B, Bessissow T, Afif W, et al
    Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review.
    Dig Dis Sci. 2021 May 21. pii: 10.1007/s10620-021-07025.
    PubMed     Abstract available


  287. CARON B, Neuville E, Peyrin-Biroulet L
    Inflammatory Bowel Disease and COVID-19 Vaccination: A Patients' Survey.
    Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07040.
    PubMed     Abstract available


  288. SYED A, Seoud T, Carleton NM, Thakkar S, et al
    Association Between Portal Vein Thrombosis and Pouchitis in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 May 4. pii: 10.1007/s10620-021-06969.
    PubMed     Abstract available


  289. JOGENDRAN R, Tandon P, Kroeker KI, Dieleman LA, et al
    A Dedicated Pregnancy Clinic Improves Reproductive Knowledge in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-06998.
    PubMed     Abstract available


  290. HAO Y, Yzet C, McBride RB, Stock A, et al
    Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis.
    Dig Dis Sci. 2021 May 2. pii: 10.1007/s10620-021-06970.
    PubMed     Abstract available


  291. WEN T, Faye AS, Lee KE, Friedman AM, et al
    Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months.
    Dig Dis Sci. 2021 May 1. pii: 10.1007/s10620-021-06999.
    PubMed     Abstract available


  292. KOCHAR BD, Cai W, Ananthakrishnan AN
    Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty.
    Dig Dis Sci. 2021 May 1. pii: 10.1007/s10620-021-06990.
    PubMed     Abstract available


  293. HASHASH JG, Mourad FH
    Perianal Fistulizing Crohn's Disease: No Shortcuts to a Deep Understanding of the Disease.
    Dig Dis Sci. 2021;66:1392-1393.
    PubMed    


  294. JIANG ZF, Zhang L
    LncRNA: A Potential Research Direction in Intestinal Barrier Function.
    Dig Dis Sci. 2021;66:1400-1408.
    PubMed     Abstract available


  295. SCHULTHEISS JPD, Altena S, Clevers MR, Baas D, et al
    Adherence to Adalimumab Was Not Improved by a Reminder-Based Intervention with an Electronic Needle Container.
    Dig Dis Sci. 2021;66:1477-1487.
    PubMed     Abstract available


  296. ZHU M, Xu X, Feng Q, Cui Z, et al
    Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Dig Dis Sci. 2021;66:1658-1668.
    PubMed     Abstract available


  297. SINGH AK, Kumar R, Gupta P, Kumar-M P, et al
    FDG-PET-CT Enterography Helps Determine Clinical Significance of Suspected Ileocecal Thickening: A Prospective Study.
    Dig Dis Sci. 2021;66:1620-1630.
    PubMed     Abstract available


  298. ROLSTON VS, Kimmel J, Popov V, Bosworth BP, et al
    Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials.
    Dig Dis Sci. 2021;66:1631-1638.
    PubMed     Abstract available


    April 2021
  299. DAI C, Huang YH
    Letter to the Editor on "Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease Patients During the SARS-CoV-2 Pandemic".
    Dig Dis Sci. 2021 Apr 29. pii: 10.1007/s10620-021-06957.
    PubMed    


  300. VIJAYVARGIYA P, Gonzalez Izundegui D, Calderon G, Tawfic S, et al
    Increased Fecal Bile Acid Excretion in a Significant Subset of Patients with Other Inflammatory Diarrheal Diseases.
    Dig Dis Sci. 2021 Apr 22. pii: 10.1007/s10620-021-06993.
    PubMed     Abstract available


  301. GUDINO V, Salas A
    Promise of Mesenchymal Stem Cell Lysates in IBD Therapy: Are the Parts Greater than the Whole?
    Dig Dis Sci. 2021;66:932-934.
    PubMed    


  302. WONG K, Isaac DM, Wine E
    Growth Delay in Inflammatory Bowel Diseases: Significance, Causes, and Management.
    Dig Dis Sci. 2021;66:954-964.
    PubMed     Abstract available


    March 2021
  303. SOO WT, Costello SP, Bryant RV
    Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Mar 25. pii: 10.1007/s10620-021-06946.
    PubMed    


  304. BARBER GE, Hendler S, Choe M, Keyashian K, et al
    Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Mar 23. pii: 10.1007/s10620-021-06947.
    PubMed     Abstract available


  305. HONAP S, Meade S, Ibraheim H, Irving PM, et al
    Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021 Mar 16. pii: 10.1007/s10620-021-06932.
    PubMed     Abstract available


  306. BAMIAS G, Kokkotis G, Gizis M, Kapizioni C, et al
    Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort.
    Dig Dis Sci. 2021 Mar 9. pii: 10.1007/s10620-021-06907.
    PubMed     Abstract available


  307. PERISETTI A, Goyal H
    Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic.
    Dig Dis Sci. 2021 Mar 3. pii: 10.1007/s10620-021-06874.
    PubMed     Abstract available


  308. CAI W, Cagan A, He Z, Ananthakrishnan AN, et al
    A Phenome-Wide Analysis of Healthcare Costs Associated with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2021;66:760-767.
    PubMed     Abstract available


    February 2021
  309. BASIL M, Schwartz D, Dalal R, Horst S, et al
    Mucosal Integrity Testing Can Detect Differences in the Rectums of Patients with Inflammatory Bowel Disease Compared to Controls: A Pilot Study.
    Dig Dis Sci. 2021 Feb 27. pii: 10.1007/s10620-021-06888.
    PubMed     Abstract available


  310. MONTENEGRO ML, Corral JE, Lukens FJ, Ji B, et al
    Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 24. pii: 10.1007/s10620-021-06899.
    PubMed     Abstract available


  311. LUO W, Tian L, Tan B, Shen Z, et al
    Update: Innate Lymphoid Cells in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 20. pii: 10.1007/s10620-021-06831.
    PubMed     Abstract available


  312. VERMA A, Varma S, Freedberg DE, Axelrad JE, et al
    A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 19. pii: 10.1007/s10620-021-06877.
    PubMed     Abstract available


  313. LLANOS-CHEA A, Shapiro JM, Winter RW, Jerger L, et al
    Lymphoma in Pediatric-Onset Inflammatory Bowel Disease Treated with Infliximab Monotherapy: A Case Series.
    Dig Dis Sci. 2021 Feb 17. pii: 10.1007/s10620-021-06884.
    PubMed     Abstract available


  314. DALAL RS, Ananthakrishnan AN, Hamilton MJ, Winter RW, et al
    Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab.
    Dig Dis Sci. 2021 Feb 11. pii: 10.1007/s10620-021-06852.
    PubMed    


  315. BARSKY M, Meserve J, Le H, Collins A, et al
    Correction to: Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06879.
    PubMed    


  316. SHIRAISHI K, Furukawa S, Yagi S, Mori K, et al
    Serum Globulin Is Associated with Endoscopic Findings and Mucosal Healing in Japanese Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 Feb 4. pii: 10.1007/s10620-021-06834.
    PubMed     Abstract available


  317. JAGT JZ, Pothof CD, Buiter HJC, van Limbergen JE, et al
    Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study.
    Dig Dis Sci. 2021 Feb 3. pii: 10.1007/s10620-021-06836.
    PubMed     Abstract available


  318. QI Y, Wu HM, Yang Z, Zhou YF, et al
    New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 1. pii: 10.1007/s10620-021-06837.
    PubMed     Abstract available


  319. GAIDOS JKJ, Kane SV
    Medication Adherence During Pregnancy in IBD: Compliance Avoids Complications.
    Dig Dis Sci. 2021;66:336-337.
    PubMed    


  320. AGRAWAL G, Aitken J, Hamblin H, Collins M, et al
    Putting Crohn's on the MAP: Five Common Questions on the Contribution of Mycobacterium avium subspecies paratuberculosis to the Pathophysiology of Crohn's Disease.
    Dig Dis Sci. 2021;66:348-358.
    PubMed     Abstract available


  321. NIV E, Ovadia B, Groisman G, Kopelman Y, et al
    CMV-Induced Severe Colonic Stricture in an Adult Crohn's Disease Patient.
    Dig Dis Sci. 2021;66:636-639.
    PubMed    


    January 2021
  322. SINH P, Tabibian JH, Biyani PS, Mehta K, et al
    Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction.
    Dig Dis Sci. 2021 Jan 25. pii: 10.1007/s10620-020-06818.
    PubMed     Abstract available


  323. GRAZIANO F, Macaluso FS, Cassata N, Citrano M, et al
    Rescue Therapy with Intensive Vedolizumab Optimization in a Seventeen-Year-Old Girl with Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2021 Jan 19. pii: 10.1007/s10620-021-06826.
    PubMed    


  324. IBORRA I, Puig M, Marin L, Calafat M, et al
    Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic.
    Dig Dis Sci. 2021 Jan 19. pii: 10.1007/s10620-020-06807.
    PubMed     Abstract available


  325. DEL VALLE JP, Lee GC, Serrato JC, Feuerstein JD, et al
    Recurrence of Clostridium Difficile and Cytomegalovirus Infections in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-Anal Anastomosis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06772.
    PubMed     Abstract available


  326. TOWNSEND CM, Khanna R, Wilson AS
    A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-alpha Antagonists.
    Dig Dis Sci. 2021 Jan 11. pii: 10.1007/s10620-020-06773.
    PubMed     Abstract available


    December 2020
  327. FIORUCCI S, Carino A, Baldoni M, Santucci L, et al
    Bile Acid Signaling in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2020 Dec 8. pii: 10.1007/s10620-020-06715.
    PubMed     Abstract available


  328. BORREN NZ, Tan W, Jess AT, Li PM, et al
    Assessment of Body Weight Changes in Patients with Inflammatory Bowel Diseases Initiating Biologic Therapy: A Prospective Cohort Study.
    Dig Dis Sci. 2020;65:3672-3678.
    PubMed     Abstract available


  329. GAO XH, Yu GY, Khan F, Li JQ, et al
    Greater Peripouch Fat Area on CT Image Is Associated with Chronic Pouchitis and Pouch Failure in Inflammatory Bowel Diseases Patients.
    Dig Dis Sci. 2020;65:3660-3671.
    PubMed     Abstract available


  330. LUO Y, Tixier EN, Grinspan AM
    Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Dig Dis Sci. 2020;65:3647-3651.
    PubMed     Abstract available


    November 2020
  331. DULAI PS, Jairath V
    A Microsimulation Model to Project the 5-Year Impact of Using Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Acute Flares.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06707.
    PubMed     Abstract available


  332. ZHANG Y, Li X, Li Y, Li Y, et al
    DNA Damage-Regulated Autophagy Modulator 1 (DRAM1) Mediates Autophagy and Apoptosis of Intestinal Epithelial Cells in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06697.
    PubMed     Abstract available


  333. BALRAM B, Joshi H, Wong K, Kroeker KI, et al
    Concomitant 5-Aminosalicylate Therapy in Moderate-to-Severe Ulcerative Colitis Patients Escalated to Infliximab Is Not Beneficial.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06704.
    PubMed     Abstract available


  334. DIBLEY L, Khoshaba B, Artom M, Van Loo V, et al
    Patient Strategies for Managing the Vicious Cycle of Fatigue, Pain and Urgency in Inflammatory Bowel Disease: Impact, Planning and Support.
    Dig Dis Sci. 2020 Nov 8. pii: 10.1007/s10620-020-06698.
    PubMed     Abstract available


  335. AXELRAD JE, Sauk JS
    Gastrointestinal Infections in IBD Flares: Can PCR-Based Stool Tests Differentiate the Smoke from the Fire?
    Dig Dis Sci. 2020;65:3064-3065.
    PubMed    


  336. PASTORELLI L, Bezzio C, Saibeni S
    Hold the Foam: Why Topical Budesonide Remains Relevant for IBD Therapy.
    Dig Dis Sci. 2020;65:3066-3068.
    PubMed    


  337. SINGH M, Singh V, Schurman JV, Friesen CA, et al
    Mucosal Th17 Cells Are Increased in Pediatric Functional Dyspepsia Associated with Chronic Gastritis.
    Dig Dis Sci. 2020;65:3184-3190.
    PubMed     Abstract available


    October 2020
  338. HOURI H, Yadegar A, Zali MR
    How Infection with C. difficile Infection Aggravates Inflammatory Bowel Disease: Is It CDI or the CDAI?
    Dig Dis Sci. 2020 Oct 23. pii: 10.1007/s10620-020-06667.
    PubMed    


  339. SCRIBANO ML
    Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06624.
    PubMed     Abstract available


  340. NGUYEN ALH, Sparrow MP
    Evolving Role of Thiopurines in Inflammatory Bowel Disease in the Era of Biologics and New Small Molecules.
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06662.
    PubMed     Abstract available


  341. KARASKOVA E, Pospisilova D, Velganova-Veghova M, Geryk M, et al
    Importance of Hepcidin in the Etiopathogenesis of Anemia in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06652.
    PubMed     Abstract available


  342. VAN GENNEP S, de Boer NKH, Gielen ME, Rietdijk ST, et al
    Impaired Quality of Working Life in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06647.
    PubMed     Abstract available


  343. SITKIN S, Pokrotnieks J
    Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06650.
    PubMed     Abstract available


  344. PANACCIONE R, Isaacs JD, Chen LA, Wang W, et al
    Correction to: Characterization of Creatine Kinase Levels in TofacitinibTreated Patients with Ulcerative Colitis: Results from Clinical Trials.
    Dig Dis Sci. 2020 Oct 10. pii: 10.1007/s10620-020-06638.
    PubMed     Abstract available


  345. COSTRINI NV
    Clearing of the Clouds in Inflammatory Bowel Disease Management.
    Dig Dis Sci. 2020 Oct 3. pii: 10.1007/s10620-020-06635.
    PubMed     Abstract available


  346. CAPPELL MS
    Improving the Safety of Endoscopy in Pregnancy: Approaching Gravidity with Gravitas.
    Dig Dis Sci. 2020;65:2745-2748.
    PubMed    


  347. WEINGARDEN AR, Smith P, Streett S, Triadafilopoulos G, et al
    A Failure to Communicate: Disentangling the Causes of Perianal Fistulae in Crohn's Disease and Anal Squamous Cell Cancer.
    Dig Dis Sci. 2020;65:2806-2809.
    PubMed    


    September 2020
  348. SMITH R, Hubers J, Farraye FA, Sampene E, et al
    Accuracy of Self-Reported Vaccination Status in a Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Sep 29. pii: 10.1007/s10620-020-06631.
    PubMed     Abstract available


  349. XIU MX, Liu YM, Chen GY, Hu C, et al
    Identifying Hub Genes, Key Pathways and Immune Cell Infiltration Characteristics in Pediatric and Adult Ulcerative Colitis by Integrated Bioinformatic Analysis.
    Dig Dis Sci. 2020 Sep 25. pii: 10.1007/s10620-020-06611.
    PubMed     Abstract available


  350. RITACCIO G, Stoleru G, Abutaleb A, Cross RK, et al
    Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
    Dig Dis Sci. 2020 Sep 7. pii: 10.1007/s10620-020-06588.
    PubMed     Abstract available


  351. BLESL A, Rainer F, Pollheimer M, Kump P, et al
    Successful Pregnancies After Regression of AA Amyloidosis by Anti-inflammatory Therapy in Chronic Active Crohn's Disease.
    Dig Dis Sci. 2020;65:2730-2734.
    PubMed    


  352. HALLE E, Azahaf M, Duveau N, Lambin T, et al
    Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohn's Disease.
    Dig Dis Sci. 2020;65:2664-2674.
    PubMed     Abstract available


  353. CERNOCH PS, Fournier N, Zeitz J, Scharl M, et al
    Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.
    Dig Dis Sci. 2020;65:2654-2663.
    PubMed     Abstract available


    August 2020
  354. SCOTT FI
    Infliximab Versus Biosimilars for IBD: Is It Better to Fight Than Switch?
    Dig Dis Sci. 2020;65:2158-2160.
    PubMed    


  355. COATES MD, Seth N, Clarke K, Abdul-Baki H, et al
    Opioid Analgesics Do Not Improve Abdominal Pain or Quality of Life in Crohn's Disease.
    Dig Dis Sci. 2020;65:2379-2387.
    PubMed     Abstract available


    July 2020
  356. BACH LE, Taleban S
    Vedolizumab (VDZ) for UC and CD: Still Safe and Effective After All These Years.
    Dig Dis Sci. 2020;65:1882-1884.
    PubMed    


  357. RIVIERE P, Laharie D
    Concise Commentary: Spaced Out-Reducing the Relapse Risk in IBD Patients by Lengthening Dosing Intervals of Anti-TNFs.
    Dig Dis Sci. 2020;65:2044-2045.
    PubMed    


  358. CRESPI M, Dulbecco P, De Ceglie A, Conio M, et al
    Strictures in Crohn's Disease: From Pathophysiology to Treatment.
    Dig Dis Sci. 2020;65:1904-1916.
    PubMed     Abstract available


  359. REINGLAS J, Gonczi L, Verdon C, Bessissow T, et al
    Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center.
    Dig Dis Sci. 2020;65:2046-2053.
    PubMed     Abstract available


  360. LI J, Liu L, Zhao Q, Chen M, et al
    Role of Interleukin-17 in Pathogenesis of Intestinal Fibrosis in Mice.
    Dig Dis Sci. 2020;65:1971-1979.
    PubMed     Abstract available


    June 2020
  361. GADHOK R, Gordon H, Sebepos-Rogers G, Baillie S, et al
    UK Patients of Bangladeshi Descent with Crohn's Disease Respond Less Well to TNF Antagonists Than Caucasian Patients.
    Dig Dis Sci. 2020;65:1790-1799.
    PubMed     Abstract available


  362. MCCURDY JD, Parlow S, Dawkins Y, Samji K, et al
    Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn's Disease.
    Dig Dis Sci. 2020;65:1784-1789.
    PubMed     Abstract available


    May 2020
  363. ZAIDI D, Wine E
    Building Fences: How A20 Protects the Intestinal Mucosa in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2020;65:1288-1290.
    PubMed    


  364. LATELLA G, Viscido A
    Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis.
    Dig Dis Sci. 2020;65:1299-1306.
    PubMed     Abstract available


  365. PAINCHART C, Brabant S, Duveau N, Nachury M, et al
    Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease.
    Dig Dis Sci. 2020;65:1445-1452.
    PubMed     Abstract available


    March 2020
  366. XU M, Cen M, Shen Y, Zhu Y, et al
    Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
    Dig Dis Sci. 2020 Mar 20. pii: 10.1007/s10620-020-06208.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.